Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.
Read Full News"I don't think it goes far enough, but it's a significant change," said one former member
Health news and commentary gathered by MedPage Today staff
At least 48 boys and young men died during initiation ceremonies in South Africa
Study address key concern with nonoperative management of appendicitis
Health news and commentary gathered by MedPage Today staff
Health news and commentary gathered by MedPage Today staff
1.
A better option for mild to moderate depression?
2.
FDA Approves New Bladder Cancer First-Line Standard of Care.
3.
A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.
4.
FDA approves Blenrep for relapsed or refractory multiple myeloma
5.
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
3.
Revolutionizing Cancer Treatment: ESMO's Updated Recommendations for Tumour NGS
4.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
5.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
2.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge